Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial-Reference-Cited by-同舟云学术

Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial

Published:1999-03 Issue:9157 Volume:353 Page:947-954
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Alton EWFW,Stern M,Farley R,Jaffe A,Chadwick SL,Phillips J,Davies J,Smith SN,Browning J,Davies MG,Hodson ME,Durham SR,Li D,Jeffery PK,Scallan M,Balfour R,Eastman SJ,Cheng SH,Smith AE,Meeker D,Geddes DM

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Abnormal regulation of ion channels in cystic fibrosis epithelia;Welsh;FASEB J,1990

2. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis;Knowles;N Engl J Med,1981

3. Pathophysiology of pulmonary disease in cystic fibrosis;Davis;Semin Respir Med,1985

4. Cystic fibrosis: current survival and population estimates to the year 2000;Elborn;Thorax,1991

5. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis;Zabner;Cell,1993

Cited by 381 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new era of targeting cystic fibrosis with non-viral delivery of genomic medicines;Advanced Drug Delivery Reviews;2024-06

2. Liposomes for Inhalation;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2024-04-01

3. Backbone cationized highly branched poly(β-amino ester)s as enhanced delivery vectors in non-viral gene therapy;Journal of Controlled Release;2024-03

4. Nanoparticle-Mediated Strategies for Enhanced Drug Penetration and Retention in the Airway Mucosa;Pharmaceutics;2023-10-13

5. Gene therapy for Cystic Fibrosis: recent advances and future prospects;Acta Naturae;2023-08-03